Clinical trials of an mRNA vaccine have begun, and researchers expect broadly positive outcomes in the fight against the widespread illness.
Antibiotics have been around for less than a century. But as resistant bacteria become increasingly difficult to treat, we risk a greater number of deaths from infections.
A review indicates that both cannabinoids and terpenes in cannabis show great promise as antivirals in laboratory research, and could be used to treat infections including COVID-19.
XBB. 1.5 and other subvariants do signal a change in how the virus is mutating. Here’s what this means for Australia and globally.
The virus is related to Hendra and Nipah viruses. But we don’t know whether it spreads from human to human.
Professor Jamie Rossjohn is internationally recognised for using structural biology to investigate how T cells can respond to viral infections or cause autoimmunity. Now, he's been named a fellow of the oldest science academy in the world.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Before COVID-19 began causing sickness, pain and death, a much bigger health threat has been evolving, and desperately needs to be stopped.
A single centralised institute dedicated to infectious diseases and planning for potential future pandemics wouldn’t work in Australia.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
... among other things lung damage, pneumonia and multi-organ failure, or sepsis.
Coronavirus infections are growing and crossing geographic borders, but what are they, and should we be worried?
Combating a virus that can cause disease and life-threatening transplant complications is the focus of Eureka Prize-winning research.
There are no approved treatments or cures, and more research is urgently needed for the debilitating illness.
Despite dire warnings of a looming antibiotic resistance crisis, the issue has failed to capture the public imagination.
After a horrific 2017 flu season, there's more interest than ever in developing a better, more universal vaccine. T-cells might hold the answer.
Dummy text
